Article Details
Retrieved on: 2024-10-26 16:53:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Keytruda (pembrolizumab) as a revolutionary immunotherapy drug in cancer treatment, highlighting its impact and prohibitive costs. It links to the concept of "Biotech" by emphasizing the biotech innovations and the pharmaceutical industry's role in developing immune-targeting antineoplastic drugs. Tags such as "Cancer immunotherapy" and "Checkpoint inhibitor" relate directly to the drug's mechanism, while discussions on affordability and accessibility reference global markets, including the United States and India.
Article found on: m.economictimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here